CEL-SCI Corp. (CVM)
1.57
-0.04
(-2.48%)
USD |
NYAM |
Aug 27, 15:25
CEL-SCI Debt to Equity Ratio : 0.721 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.721 |
| March 31, 2026 | 1.238 |
| December 31, 2025 | 0.8175 |
| September 30, 2025 | 0.5881 |
| June 30, 2025 | 1.418 |
| March 31, 2025 | 1.317 |
| December 31, 2024 | 0.9803 |
| September 30, 2024 | 0.9032 |
| June 30, 2024 | 1.432 |
| March 31, 2024 | 0.883 |
| December 31, 2023 | 1.036 |
| September 30, 2023 | 1.027 |
| June 30, 2023 | 0.948 |
| March 31, 2023 | 0.7177 |
| December 31, 2022 | 0.5599 |
| September 30, 2022 | 0.4758 |
| June 30, 2022 | 0.4052 |
| March 31, 2022 | 0.3556 |
| December 31, 2021 | 0.3043 |
| September 30, 2021 | 0.2825 |
| June 30, 2021 | 0.2552 |
| March 31, 2021 | 0.452 |
| December 31, 2020 | 0.4749 |
| September 30, 2020 | 0.7065 |
| June 30, 2020 | 0.6778 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9918 |
| December 31, 2019 | 1.592 |
| September 30, 2019 | 2.631 |
| June 30, 2019 | 11.76 |
| March 31, 2019 | 14.07 |
| December 31, 2018 | 4.954 |
| September 30, 2018 | 14866.67 |
| June 30, 2018 | -10.66 |
| March 31, 2018 | -4.732 |
| December 31, 2017 | -2.923 |
| September 30, 2017 | -4.257 |
| June 30, 2017 | -2.652 |
| March 31, 2017 | -4.629 |
| December 31, 2016 | 2.782 |
| September 30, 2016 | -19.16 |
| June 30, 2016 | -0.0006 |
| March 31, 2016 | -0.0016 |
| December 31, 2015 | 0.3146 |
| September 30, 2015 | -0.2406 |
| June 30, 2015 | 3.423 |
| March 31, 2015 | 28.28 |
| December 31, 2014 | 0.4158 |
| September 30, 2014 | 0.6345 |
| June 30, 2014 | 0.0747 |
| March 31, 2014 | 1.647 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.36M |
| Total Liabilities (Quarterly) | 10.40M |
| Shareholders Equity (Quarterly) | 10.96M |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 2.88% |